Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
出版年份 2018 全文链接
标题
Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
作者
关键词
-
出版物
Cancers
Volume 10, Issue 10, Pages 390
出版商
MDPI AG
发表日期
2018-10-23
DOI
10.3390/cancers10100390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meeting the needs of breast cancer: A nucleolin’s perspective
- (2018) Ana C. Gregório et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin
- (2017) Sanjeev Kumar et al. Scientific Reports
- Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
- (2017) Virginie Marcel et al. PLoS One
- Research needs in breast cancer
- (2016) F. Cardoso et al. ANNALS OF ONCOLOGY
- Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
- (2016) Maud-Emmanuelle Gilles et al. CANCER RESEARCH
- Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
- (2016) Eya Wolfson et al. Oncotarget
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Centrosomal nucleolin is required for microtubule network organization
- (2015) Xavier Gaume et al. CELL CYCLE
- Human anti-nucleolin recombinant immunoagent for cancer therapy
- (2015) Dario Palmieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy
- (2014) XiaoDong Guo et al. Diagnostic Pathology
- Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer
- (2013) Wensheng Qiu et al. APMIS
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer
- (2013) Hongyun Zhao et al. PLoS One
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
- (2010) L. Peng et al. CLINICAL CANCER RESEARCH
- Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
- (2010) Ara G. Hovanessian et al. PLoS One
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma
- (2008) Lee Ridley et al. NEURO-ONCOLOGY
- Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin
- (2008) Damien Destouches et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started